Delivery Order SPE2DB20D2104-SPE2DB22FQ65W
- Not listed
- The federal contract award is for the pharmaceutical product Repatha 140 mg/ml SureClick, with a total ceiling value of $1,753.30. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a period of performance running through February 2025. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award is for the pharmaceutical product Repatha 140 mg/ml SureClick, with a ceiling value of $2,251.70. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick, a specialty pharmaceutical product. The contract, valued at $4,487.76, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as a...
- This federal contract award is for the pharmaceutical product Repatha 140 mg/mL SureClick, awarded to the prime contractor Amerisourcebergen Drug Corp. The $37,299.26 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 6, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds...
- This federal contract award is for the pharmaceutical product Repatha 140 mg/ml SureClick. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $18,929.40. It has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Repatha 140 mg/mL SureClickTM medication to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The $1,016.82 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA). The $7,167.57 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of Repatha, a 140 mg/mL SureClick medication, placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,205.07 firm-fixed-price delivery order has a completion date of January 29, 2024. Amerisourcebergen, a for-profit organization, is the prime contractor, and there is no indication of any set-aside designation. The contract is part of Amerisourcebergen's larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Repatha 140 mg/mL SureClick medication. The $3,537.60 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award is for the medical product Repatha 140 mg/mL SureClick. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $2,037.39 and an ultimate completion date of November 20, 2023. It is a delivery order contract with a firm fixed price pricing type. The award was not designated with a set-aside. Amerisourcebergen Drug Corp holds a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FQ65WDelivery Order
This federal contract award is for the pharmaceutical product Repatha 140 mg/ml SureClick. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,022.92, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 10/7/21 |